Professor | Yinghui Zhu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yinghui Zhu
Contact Information	zhuyinghui@tongji.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Yinghui Zhu

Contact Information

zhuyinghui@tongji.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Tongji University
Faculty	Life Sciences
Academic Background & Achievements	2010.9-2016.1 PhD: Beijing Institute of Genomics, Chinese Academy of Sciences Selected for Shanghai Overseas High-Level Talent Plan
Work Experience	2023.2 to present - Tongji University Affiliated Oriental Hospital, Translational Medicine Center; Researcher 2022.9 to present - School of Life Sciences and Technology / Advanced Research Institute, Tongji University; Distinguished Researcher 2016.3-2020 - City of Hope National Medical Center, USA; Postdoctoral Fellow/Staff Scientist

University/Lab Affiliation and Title

Tongji University

Faculty

Life Sciences

Academic Background & Achievements

2010.9-2016.1 PhD: Beijing Institute of Genomics, Chinese Academy of Sciences
Selected for Shanghai Overseas High-Level Talent Plan

Work Experience

2023.2 to present - Tongji University Affiliated Oriental Hospital, Translational Medicine Center; Researcher
2022.9 to present - School of Life Sciences and Technology / Advanced Research Institute, Tongji University; Distinguished Researcher
2016.3-2020 - City of Hope National Medical Center, USA; Postdoctoral Fellow/Staff Scientist

Areas of Focus	Pathogenesis and resistance mechanisms of acute leukemia Development of targeted immunotherapies for leukemia
Publications	Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax plus 3+7 Chemotherapy in AML, Jin J, Hou SY, Yao YY, Mao LP, Yang M, Tong HY, Zeng T, Huang JY, Zhu YH, Wang HF, 2023 Identification of a novel NPM1 mutation in acute myeloid leukemia, Yao YY, Lin XJ, Wang C, Gu Y, Jin J, Zhu YH, Wang HF, 2023 CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNγ-induced CD38 expression, Murtadha M, Park M, Zhu YH, Caserta E, Napolitano O, Tandoh T, Moloudizargari M, Pozhitkov A, Singer M, Dona AA, Vahed H, Gonzalez A, Ly K, Ouyang C, Sanchez JF, Nigam L, Chowdhury A, Ghoda L, Li L, Zhang B, Krishnan A, Marcucci G, Williams JC, Pichiorri F, 2024

Areas of Focus

Pathogenesis and resistance mechanisms of acute leukemia
Development of targeted immunotherapies for leukemia

Publications

Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax plus 3+7 Chemotherapy in AML, Jin J, Hou SY, Yao YY, Mao LP, Yang M, Tong HY, Zeng T, Huang JY, Zhu YH, Wang HF, 2023
Identification of a novel NPM1 mutation in acute myeloid leukemia, Yao YY, Lin XJ, Wang C, Gu Y, Jin J, Zhu YH, Wang HF, 2023
CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNγ-induced CD38 expression, Murtadha M, Park M, Zhu YH, Caserta E, Napolitano O, Tandoh T, Moloudizargari M, Pozhitkov A, Singer M, Dona AA, Vahed H, Gonzalez A, Ly K, Ouyang C, Sanchez JF, Nigam L, Chowdhury A, Ghoda L, Li L, Zhang B, Krishnan A, Marcucci G, Williams JC, Pichiorri F, 2024

Acute Leukemia Pathogenesis Resistance Mechanisms Targeted Therapy Immunotherapy Clinical Application High-Throughput Proteomics Metabolomics Clinical Translation

Yinghui Zhu - Tongji University

Xin-Yuan Liu - University of Chinese Academy of Sciences

Lei Sun - Fudan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us